drugset / Trial / NCT01975194
Rosuvastatin in African Americans With Cerebrovascular Disease
NaSingle-groupOpen-labelTreatment
Summary
This study will assess the rate at which rosuvastatin will achieve LDL targets in African American patients with previous history of stroke or TIA.
Timeline
- Start
- 2012-01
- Primary completion
- 2013-08
- Completion
- 2013-08
Outcome
Outcome not reported
Stopped: “loss of research personnel”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 20 mg | — |
| Subject | Rosuvastatin | Small molecule | 40 mg | — |